Dr Pedro Machado: Targeting protein homeostasis as a novel therapeutic approach in sporadic inclusion body myositis
12:45pm - 1:45pm /
Wednesday 1st June 2016
/ Venue: Ground floor Apex Building
- 0151 794 9003
- Brenda Smith
- Admission: Free to staff and students
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Dr Pedro Machado is an NIHR Clinical Post-Doctoral Fellow, based in the MRC Centre for Neuromuscular Diseases, University College London. He is also an Honorary Consultant in Rheumatology and Muscle Diseases at University College London Hospitals NHS Foundation Trust.
His primary research interest is the investigation of new therapeutic strategies in muscle diseases, particularly in Inclusion Body Myositis, a debilitating and currently untreatable muscle disorder. He also has an interest in the assessment (including MRI) and prediction of outcomes in rheumatic diseases, with a focus on muscle diseases and in axial spondyloarthritis.
His primary research interest is the investigation of new therapeutic strategies in muscle diseases, particularly in Inclusion Body Myositis, a debilitating and currently untreatable muscle disorder. He also has an interest in the assessment (including MRI) and prediction of outcomes in rheumatic diseases, with a focus on muscle diseases and in axial spondyloarthritis.